mTOR inhibitors also play a crucial role in treating the neuropsychiatric symptoms of mTORopathies, such as tuberous sclerosis, by modulating the mTOR pathway, which is dysregulated in these conditions. Here, MTOR is linked to tuberous sclerosis.